409 related articles for article (PubMed ID: 24160707)
1. Recent progress in the development of histone deacetylase inhibitors as anti-cancer agents.
Zhang L; Lei J; Shan Y; Yang H; Song M; Ma Y
Mini Rev Med Chem; 2013 Dec; 13(14):1999-2013. PubMed ID: 24160707
[TBL] [Abstract][Full Text] [Related]
2. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
3. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
Ho TCS; Chan AHY; Ganesan A
J Med Chem; 2020 Nov; 63(21):12460-12484. PubMed ID: 32608981
[TBL] [Abstract][Full Text] [Related]
4. [Structure-activity relationships of histone deacetylase inhibitors].
Tan YM; Huang WY; Yu NF
Yao Xue Xue Bao; 2009 Oct; 44(10):1072-83. PubMed ID: 20055127
[TBL] [Abstract][Full Text] [Related]
5. Antitumor action of a novel histone deacetylase inhibitor, YF479, in breast cancer.
Zhang T; Chen Y; Li J; Yang F; Wu H; Dai F; Hu M; Lu X; Peng Y; Liu M; Zhao Y; Yi Z
Neoplasia; 2014 Aug; 16(8):665-77. PubMed ID: 25220594
[TBL] [Abstract][Full Text] [Related]
6. Identification of type-specific anticancer histone deacetylase inhibitors: road to success.
Noureen N; Rashid H; Kalsoom S
Cancer Chemother Pharmacol; 2010 Sep; 66(4):625-33. PubMed ID: 20401613
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in histone deacetylase targeted cancer therapy.
Hoshino I; Matsubara H
Surg Today; 2010 Sep; 40(9):809-15. PubMed ID: 20740342
[TBL] [Abstract][Full Text] [Related]
8. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.
Li X; Hou J; Li X; Jiang Y; Liu X; Mu W; Jin Y; Zhang Y; Xu W
Eur J Med Chem; 2015 Jan; 89():628-37. PubMed ID: 25462271
[TBL] [Abstract][Full Text] [Related]
9. Macrocyclic histone deacetylase inhibitors.
Mwakwari SC; Patil V; Guerrant W; Oyelere AK
Curr Top Med Chem; 2010; 10(14):1423-40. PubMed ID: 20536416
[TBL] [Abstract][Full Text] [Related]
10. Natural products as zinc-dependent histone deacetylase inhibitors.
Tan S; Liu ZP
ChemMedChem; 2015 Mar; 10(3):441-50. PubMed ID: 25581683
[TBL] [Abstract][Full Text] [Related]
11. Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment.
Peng X; Sun Z; Kuang P; Chen J
Eur J Med Chem; 2020 Dec; 208():112831. PubMed ID: 32961382
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors and cell death.
Zhang J; Zhong Q
Cell Mol Life Sci; 2014 Oct; 71(20):3885-901. PubMed ID: 24898083
[TBL] [Abstract][Full Text] [Related]
13. The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker.
Yang F; Zhao N; Hu Y; Jiang CS; Zhang H
Chem Biodivers; 2020 Jan; 17(1):e1900427. PubMed ID: 31793143
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2012 Jan; 32(1):1-165. PubMed ID: 20162725
[TBL] [Abstract][Full Text] [Related]
15. Selective Histone Deacetylase Inhibitors with Anticancer Activity.
Ma N; Luo Y; Wang Y; Liao C; Ye WC; Jiang S
Curr Top Med Chem; 2016; 16(4):415-26. PubMed ID: 26268343
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
[TBL] [Abstract][Full Text] [Related]
17. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
18. Zinc binding groups for histone deacetylase inhibitors.
Zhang L; Zhang J; Jiang Q; Zhang L; Song W
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):714-721. PubMed ID: 29616828
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of thiophene-based hydroxamate derivatives as HDACis with antitumor activities.
Yang F; Han L; Zhao N; Yang Y; Ge D; Zhang H; Chen Y
Future Med Chem; 2020 Apr; 12(8):655-672. PubMed ID: 32202140
[No Abstract] [Full Text] [Related]
20. Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery.
Amin SA; Adhikari N; Jha T
Future Med Chem; 2017 Dec; 9(18):2211-2237. PubMed ID: 29182018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
